|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2010-6-10
|
|
pubmed:abstractText |
The purpose of this study was to evaluate the effect of individualized repeated intravitreal injections of ranibizumab (Lucentis, Genentech, South San Francisco, CA) on visual acuity and central foveal thickness (CFT) for branch retinal vein occlusion-induced macular edema.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1539-2864
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
30
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
893-902
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:20531142-Aged,
pubmed-meshheading:20531142-Angiogenesis Inhibitors,
pubmed-meshheading:20531142-Antibodies, Monoclonal,
pubmed-meshheading:20531142-Antibodies, Monoclonal, Humanized,
pubmed-meshheading:20531142-Female,
pubmed-meshheading:20531142-Fluorescein Angiography,
pubmed-meshheading:20531142-Follow-Up Studies,
pubmed-meshheading:20531142-Humans,
pubmed-meshheading:20531142-Injections,
pubmed-meshheading:20531142-Macular Edema,
pubmed-meshheading:20531142-Male,
pubmed-meshheading:20531142-Middle Aged,
pubmed-meshheading:20531142-Prospective Studies,
pubmed-meshheading:20531142-Retinal Vein Occlusion,
pubmed-meshheading:20531142-Retreatment,
pubmed-meshheading:20531142-Tomography, Optical Coherence,
pubmed-meshheading:20531142-Treatment Outcome,
pubmed-meshheading:20531142-Visual Acuity,
pubmed-meshheading:20531142-Vitreous Body
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Intravitreal ranibizumab (Lucentis) for branch retinal vein occlusion-induced macular edema: nine-month results of a prospective study.
|
|
pubmed:affiliation |
Ophthalmology Department, ATTIKON Hospital, University of Athens, Athens, Greece.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
